STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. (16th September 2021)

Record Type:: Journal Article
Title:: STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. (16th September 2021)
Main Title:: STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy
Authors:: Gerthofer, Valeria
Scheiter, Alexander
Lüke, Florian
Keil, Felix
Utpatel, Kirsten
Pöhmerer, Laura-Maria-Giovanna
Seitz, Johannes
Niessen, Christoph
Ignatov, Atanas
Dietmaier, Wolfgang
Calvisi, Diego F.
Evert, Matthias
Ortmann, Olaf
Seitz, Stephan
Abstract:
Is Part Of:: JCO precision oncology. Volume 5(2021)
Journal:: JCO precision oncology
Issue:: Volume 5(2021)
Issue Display:: Volume 5, Issue 2021 (2021)
Year:: 2021
Volume:: 5
Issue:: 2021
Issue Sort Value:: 2021-0005-2021-0000
Page Start:: 1507
Page End:: 1513
Publication Date:: 2021-09-16
Subjects:: Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:: http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1200/PO.21.00184 ↗
Languages:: English
ISSNs:: 2473-4284
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22801.xml